Clinical Trials · NCT07628985
BALANCE-DM2 Study of Bofanglutide in Adults With Type 2 Diabetes
- Phase
- Phase 3
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Carnot Laboratories
- Enrollment
- 374
- Start date
- Sep 2026
- Locations
- 7 sites, Mexico
- Primary endpoint
- Change in Hemoglobin A1c (HbA1c) From Baseline at Week 30